Work Medical Technology Group Ltd · NASDAQ:WOK
Work Medical Technology — IPO Roadshow (March 2024)
23 slides from Work Medical Technology's IPO roadshow presentation, Mar 25, 2024
Slide 1: Investor Presentation March 2024
Issuer Free Writing Prospectus dated March 25, 2024 Filed Pursuant to Rule 433 of the Securities Act of 1933, as amended Relating to Preliminary Prospectus dated March 20, 2024 Registration Statement No. 333 - 271474 WORK Medical Technology Group LTD Investor Presentation March 2024
Slide 2: Free Writing Prospectus Statement
Free Writing Prospectus Statement This free writing prospectus (the “presentation”) relates to the proposed public offering of ordinary shares, par value $ 0 . 0005 per share (“Ordinary Shares”) of WORK Medical Technology Group LTD (“the Company,” “we, ” “us, ” or “our . ”) and should be read togeth
Slide 3: Forward-Looking Statement
Forward - Looking Statement This presentation contains forward - looking statements, including those listed under “Risk Factors” in the Registration Statement, which may cause our actual results, performance or achievements to be materially different from those expressed or implied therein . You can
Slide 4: Preliminary Offering Summary
Preliminary Offering Summary WORK Medical Technology Group LTD Issuer Ordinary Shares Securities Initial Public Offering Offering Type Nasdaq Capital Market: WOK Proposed Listing/Symbol 2,000,000 Ordinary Shares, plus up to an additional 300,000 Ordinary Shares, if the underwriter exercises its over
Slide 5: Corporate Structure Outside the PRC
Corporate Structure 5 Outside the PRC WORK Medical Technology Group Limited “Work BVI” British Virgin Islands, 2022 WORK Medical Technology Group LTD “Work Cayman” Cayman,2022 Pre - IPO%/Post - IPO% LWY GROUP LTD British Virgin Islands, 2022 (1) Other Minority Shareholders (2) SANYOU NO.1 GROUP LTD
Slide 6: Company Overview
Company Overview We are a supplier of medical devices in China. We develop and manufacture Class I and II medical devices and sell Class I and II disposable medical devices through operating subsidiaries in China. Our mission is to become a world - leading manufacturer of medical devices, and we are
Slide 7: Company Overview
Company Overview Shanghai Saitumofei Medical Treatment Technology Co., Ltd. focuses on the research and development of Class II and III medical devices, and biological and medical technology Research and Development Core Production Base and Domestic and Overseas Sales Chemical Products Sales Medical
Slide 8: Products
Products • We have a total of 21 medical devices in our product portfolio. • All of them are sold domestically and 15 of them are sold internationally. Our select products are as follows: Select Products Product in Pipeline Visualized Prostatic Dilatation Catheter • Hangzhou Shanyou received the Med
Slide 9: Customers
Customers Direct End - user Customer • 140 direct end - user customers from hospitals, pharmacies, medical institutions Our 1,054 Customers Domestic Distributor Customer • 892 domestic distributor customers • Cover 34 provincial - level administrative regions in China Export Distributor Customer • 2
Slide 10: Quality Control Process Flow Diagrams
Quality Control Process Flow Diagrams The Quality Control Management System Earned Quality - related Manufacturing Designations Our quality control management system comprehensively covers all manufacturing processes: • Raw Materials Inspection • Production Check • Product Examination • Specifying t
Slide 11: Investment Highlights
Investment Highlights Deep Understanding of the Industry Cost - effective Masks Customized and Multifunctional Masks 11 See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a
Slide 12: Industry Overview: Growth Rate of Medical Device Market
Industry Overview Growth Rate of Medical Device Market Size of China and the World 2012 - 2025 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 2012 2018 2024E 2013 2014 2015 2016 2017 Growth Rate of Global Medical Devices Market Size 2019 2020 2021 2022 2023E Growth Rate of Medical Devices Mar
Slide 13: Industry Overview: Forecast of Seven Largest Medical Device Markets in 2030
Industry Overview Forecast of Sales Size of Seven Largest Medical Device Markets in 2030 3,050 13 Source: KPMG, Medical Device Industry 2030 Outlook See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achieved. Investments may be speculat
Slide 14: Industry Overview: China Medical Device Market and Opportunities
Industry Overview 0 14 Source: Southern Institute of Medical Economics, 2023 Report on the Development of China’s Medical Device Industry. See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiq
Slide 15: Deep Understanding of the Industry
Deep Understanding of the Industry • 42 registered patents, 17 products registered with FDA, 3 products with CE Certification (1) Note: (1) As of the date of this presentation. 15 See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achiev
Slide 16: Cost-effective Masks, and Customized and Multifunctional Masks
Cost - effective Masks, and Customized and Multifunctional Masks • The PRC subsidiaries upgraded their production equipment. They are able to manufacture more cost - effective products • After transforming the production lines into fully automated ones, and putting automatic headband mask machines i
Slide 17: Wide Distribution Network
Wide Distribution Network • Exporting distributors span across 6 continents • Sold the products in 30+ countries 7.20% 7.13% 92.80% 92.87% Oversea Domestic Revenue Disaggregates by Geographic Market • Reach approximately 50 global customers (1) Our Global Presence FY2022 (2) FY2023 (2) 17 Note: (1)
Slide 18: Experienced Management Team
Experienced Management Team Shuang Wu Chief Executive Officer, Director Chairman of the Board of Directors • Mr. Wu has extensive managerial and financial experience. • Chief Operating Officer of EZGO Technologies Ltd (Nasdaq: EZGO) from August 2019 to May 2022. • Vice president of Changzhou Hengmao
Slide 19: Independent Directors
Independent Directors Xiaoyang Li Independent Director Appointee • Mr. Li’s law practices cover multiple including IPO, merger and acquisition, fields, private equity, foreign direct investment, and commercial arbitration. • Senior partner of DeHeng Law Office (Shenzhen) since March 2008 . • Attorne
Slide 20: Growth Strategies
Growth Strategies Continue to invest in the PRC subsidiaries’ R&D team • We plan to deepen the PRC subsidiaries’ collaboration with medical institutions and invest additional capital in R&D on technology and new product to add new items to the product portfolio Expand the PRC subsidiaries’ sales and
Slide 21: Financial Highlights
Financial Highlights 19.71 13.57 FY2022 FY2023 Revenue US$ Million Revenue Breakdown 53.87% 44.38% 0.54% 1.21% FY2022 FY2023 Mask Medical device other than mask Others Commodity trading 37.53% 58.95% 2.40% 1.12% 21 Note: Fiscal year ended September 30. See offering documents for risks and further di
Slide 22: Financial Highlights
Financial Highlights 2.35 3.23 FY2022 FY2023 22.41% 30.54% FY2022 FY2023 Total Working Capital Gross Profit Margin US$ Million 22 Note: Fiscal year ended September 30. See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achieved. Investme
Slide 23: Contacts
Contacts Issuer: WORK Medical Technology Group LTD Underwriter: Univest Securities, LLC Email: ir@workmedtech.com Tel: +86 - 0571 - 82613568 Address: Building 23, No. 2 Tonghuinan Rd., Xiaoshan District, Hangzhou, China, 311200 Email: info@univest.us Tel: +1 - 212 - 343 - 8888 Address: 75 Rockefelle
WORK Medical Technology Group — IPO Roadshow (March 2024) on 6ix